Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration.

The role played by oxidative stress in amiodarone-induced mitochondrial toxicity is debated. Dronedarone shows pharmacological properties similar to those of amiodarone but several differences in terms of toxicity. In this study, we analyzed the effects of the two drugs on liver mitochondrial function by administering an equivalent human dose to a rat model. Amiodarone increased mitochondrial H(2)O(2) synthesis, which in turn induced cardiolipin peroxidation. Moreover, amiodarone inhibited Complex I activity and uncoupled oxidative phosphorylation, leading to a reduction in the hepatic ATP content. We also observed a modification of membrane phospholipid composition after amiodarone administration. N-acetylcysteine completely prevented such effects. Although dronedarone shares with amiodarone the capacity to induce uncoupling of oxidative phosphorylation, it did not show any of the oxidative effects and did not impair mitochondrial bioenergetics. Our data provide important insights into the mechanism of mitochondrial toxicity induced by amiodarone. These results may greatly influence the clinical application and toxicity management of these two antiarrhythmic drugs.

[1]  Bernhard Kadenbach,et al.  Intrinsic and extrinsic uncoupling of oxidative phosphorylation. , 2003, Biochimica et biophysica acta.

[2]  R Bracher,et al.  Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. , 2001, Journal of hepatology.

[3]  W. Ho,et al.  A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. , 2002, Analytical biochemistry.

[4]  J. Sastre,et al.  Ursodeoxycholic acid , 2023, Reactions weekly.

[5]  N. Parinandi,et al.  Assay of cardiolipin peroxidation by high-performance liquid chromatography. , 1988, Chemistry and physics of lipids.

[6]  G. Hindricks,et al.  Treating arrhythmias: an expert opinion , 2011, Expert opinion on pharmacotherapy.

[7]  S. Rabkin Effect of Amiodarone on Phospholipid Content and Composition in Heart, Lung, Kidney and Skeletal Muscle: Relationship to Alteration of Thyroid Function , 2006, Pharmacology.

[8]  M. Portero-Otín,et al.  Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  F. Bellanti,et al.  Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart , 2007, Redox report : communications in free radical research.

[10]  H. Terada,et al.  Uncouplers of oxidative phosphorylation. , 1990, Environmental health perspectives.

[11]  P. Heytler [58] Uncouplers of oxidative phosphorylation , 1979 .

[12]  J. Tocanne,et al.  Interactions of amiodarone with model membranes and amiodarone-photoinduced peroxidation of lipids. , 1992, Biochemical pharmacology.

[13]  L. Siddoway Amiodarone: guidelines for use and monitoring. , 2003, American family physician.

[14]  R. Trohman,et al.  Prescribing amiodarone: an evidence-based review of clinical indications. , 2007, JAMA.

[15]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[16]  P. Armstrong,et al.  Amiodarone hepatotoxicity simulating alcoholic liver disease. , 1984, The New England journal of medicine.

[17]  C. J. Sinal,et al.  Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in mice. , 2010, Pharmacological research.

[18]  G. Poli,et al.  4-Hydroxynonenal is Markedly Higher in Patients on a Standard Long-term Home Parenteral Nutrition , 2004, Free radical research.

[19]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[20]  S. Papa,et al.  Cooperative proton-transfer reactions in the respiratory chain: redox bohr effects. , 1986, Methods in enzymology.

[21]  R. Houtkooper,et al.  Cardiolipin, the heart of mitochondrial metabolism , 2008, Cellular and Molecular Life Sciences.

[22]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.

[23]  Christopher J Sinal,et al.  Disruption of Hepatic Lipid Homeostasis in Mice after Amiodarone Treatment Is Associated with Peroxisome Proliferator-Activated Receptor-αTarget Gene Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[24]  F. Cuccurullo,et al.  Antioxidant activity of amiodarone on human lipoprotein oxidation , 2001, British journal of pharmacology.

[25]  M. Ahmad,et al.  Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.

[26]  J. Mason Drug therapy: amiodarone , 1987 .

[27]  D. Pessayre,et al.  Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. , 1998, Gastroenterology.

[28]  G. Paradies,et al.  Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. , 2009, Cell calcium.

[29]  E. Downar,et al.  Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. , 1984, Gastroenterology.

[30]  S. Albert,et al.  Effects of amiodarone on serum lipoprotein levels. , 1991, The American journal of cardiology.

[31]  L. Siculella,et al.  Hypothyroidism down-regulates mitochondrial citrate carrier activity and expression in rat liver. , 2006, Biochimica et biophysica acta.

[32]  A. Romano,et al.  Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia–reperfusion injury , 2008, Gut.

[33]  G. Labbe,et al.  Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. , 1990, The Journal of pharmacology and experimental therapeutics.

[34]  F. Cuccurullo,et al.  Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation. , 2007, Biochemical pharmacology.

[35]  D. Pessayre,et al.  Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. , 1990, The Journal of pharmacology and experimental therapeutics.

[36]  Martin D. Brand,et al.  Body mass dependence of H+ leak in mitochondria and its relevance to metabolic rate , 1993, Nature.

[37]  Nihal Ahmad,et al.  Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Carruthers,et al.  Elevation of serum total cholesterol and triglyceride levels during amiodarone therapy. , 1988, The American journal of cardiology.

[39]  H. Vieira,et al.  Glutathionylation of Adenine Nucleotide Translocase Induced by Carbon Monoxide Prevents Mitochondrial Membrane Permeabilization and Apoptosis* , 2010, The Journal of Biological Chemistry.

[40]  A. Campello,et al.  Effect of amiodarone (AMD) on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism , 1997, Cell biochemistry and function.

[41]  S. Nattel,et al.  New antiarrhythmic drugs for treatment of atrial fibrillation , 2010, The Lancet.

[42]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[43]  A. Ghelli,et al.  The mechanism of proton and electron transport in mitochondrial complex I. , 1994, Biochimica et biophysica acta.

[44]  A. Barrientos In vivo and in organello assessment of OXPHOS activities. , 2002, Methods.

[45]  G. Azzone,et al.  The nature of mitochondrial respiration and discrimination between membrane and pump properties. , 1995, The Biochemical journal.

[46]  E. Aliot,et al.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.